TikToker's tirzepatide injection switch raises key questions

What does this video actually claim?

@joannasgettinghealthy shares her decision to switch from two injections to one by moving her tirzepatide shot to her arm. She mentions using the medication for PCOS and weight loss, expressing hope that the arm will be a better injection site than wherever she was injecting before.

The video doesn't make explicit medical claims but suggests that injection site changes might improve her experience with the medication. She's clearly using tirzepatide as part of her weight management strategy for PCOS.

Is switching injection sites actually beneficial?

There's no clinical evidence that injection site affects tirzepatide's effectiveness for weight loss. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed 22.5% weight loss with 15mg tirzepatide, but didn't compare injection sites.

The FDA-approved sites for tirzepatide are the thigh, abdomen, and upper arm. All three areas absorb the medication similarly. Some people do report different comfort levels or injection reactions depending on the site, but this is individual preference rather than medical necessity.

Her mention of going from "2 shots" to "one shot" is confusing. Tirzepatide is always given as a single weekly injection, not two separate shots.

What's the connection between tirzepatide and PCOS?

Tirzepatide isn't FDA-approved specifically for PCOS, but weight loss can help manage PCOS symptoms. Women with PCOS often have insulin resistance, and tirzepatide improves insulin sensitivity while promoting significant weight loss.

The SURMOUNT-1 trial included some participants with PCOS-related metabolic issues. At 72 weeks, participants lost an average of 20.9% body weight on 15mg tirzepatide versus 3.1% on placebo.

Many doctors prescribe GLP-1 medications off-label for PCOS-related weight management. The weight loss can improve insulin resistance, hormone levels, and menstrual regularity in women with PCOS.

Are there risks to frequent injection site changes?

Rotating injection sites is actually recommended, not risky. The prescribing information for tirzepatide (Mounjaro/Zepbound) specifically advises rotating injection sites within the same body area or between different areas.

Repeated injections in the exact same spot can cause lipodystrophy, where fat tissue breaks down or builds up abnormally. This can affect how well the medication absorbs.

However, you shouldn't change sites randomly. Stick with one area for consistency, then rotate within that area. Some people do report different side effect profiles when switching between abdomen, thigh, and arm injections.

What should people actually know about tirzepatide injections?

Tirzepatide requires a single weekly injection, period. If someone thinks they need two shots, they're either confused about the dosing or using a different medication entirely.

The starting dose is 2.5mg weekly, increasing every four weeks until you reach your maintenance dose. Maximum dose is 15mg weekly for weight management. You can inject in your thigh, abdomen, or upper arm.

For PCOS specifically, tirzepatide can be effective for weight loss, but it's expensive (around $1,000+ monthly without insurance) and requires ongoing use. The weight typically returns when you stop the medication.